长读长定序市场规模、份额和成长分析（按产品、技术、工作流程、应用、用途、最终用户和地区划分）－2026-2033年产业预测

预计到 2024 年，全球长读定序市场规模将达到 7.7992 亿美元，从 2025 年的 10.2092 亿美元成长到 2033 年的 88.049 亿美元，在预测期（2026-2033 年）内复合年增长率为 30.9%。

全球长读长定定序(LRS) 市场的发展主要受遗传疾病发生率上升、个人化医疗需求成长以及第三代定序等技术进步的推动。尤其值得一提的是，全球健康危机促使人们对创新定序技术的需求激增，因为效用。 LRS，包括单分子即时定序 (SMRT) 和奈米孔定序等技术，具有许多显着优势，例如能够检测传统定序难以识别的复杂基因组特征，以及实现精准的基因组组装。凭藉其分析复杂基因区域和染色体异常的强大能力，LRS 已成为临床研究的关键工具。同时，产业领导者对先进基因组技术的大规模投资预计将进一步推动市场成长。

全球长读长定序市场驱动因素

全球长读长定序市场的发展主要得益于次世代定序（NGS）技术在基因体学、转录组学和表观基因等多个研究领域的广泛应用。长读长定序能够显着提升对基因组组装、基因表现和DNA修饰模式的理解，这极大地促进了其在以NGS为核心的研究倡议中的日益普及和整合。研究人员越来越依赖这项技术来获取更深入的见解和更全面的数据，从而推动各个科学领域的创新和进步，并促进其在全球研究界的广泛应用。

压制全球长读长定序市场

全球长读长定序市场面临挑战，因为与传统的短读长定序方法相比，这些技术的成本相对较高。这种经济负担主要源自于专用设备、试剂和全面数据分析的成本，而这些成本可能相当可观。这个经济因素可能会阻碍长读长定定序在各种环境中的广泛应用，尤其是在资源有限的临床诊断和研究实验室。因此，成本方面的考虑可能会限制这些先进定序解决方案在更常规的应用和环境中的整合。

全球长读长定序市场趋势

随着研究人员和医疗专业人员日益认识到长读长定序技术在提供详细、精确的基因组分析方面的优势，全球长读长定序市场正经历强劲成长。这一转变是由基因组组装、结构变异分析和转录组学等多个应用领域需求的激增所驱动。随着传统短读长定定序的限制日益凸显，人们对能够分析复杂遗传环境的创新解决方案的兴趣也日益浓厚。预计长读长定序技术的持续进步将进一步推动其应用，增强科研能力，并促进个人化医疗的发展。

目录

介绍

• 调查目标
• 调查范围
• 定义

调查方法

• 资讯收集
• 二手资料和一手资料方法
• 市场规模预测
• 市场假设与限制

执行摘要

• 全球市场展望
• 供需趋势分析
• 细分市场机会分析

市场动态与展望

• 市场规模
• 市场动态
  • 驱动因素和机会
  • 限制与挑战
• 波特分析

关键市场考察

• 关键成功因素
• 竞争程度
• 关键投资机会
• 市场生态系统
• 市场吸引力指数（2025）
• PESTEL 分析
• 总体经济指标
• 价值链分析
• 定价分析
• 技术进步
• 监管环境

全球长读长定序市场规模（依产品类型及复合年增长率划分）（2026-2033 年）

• 消耗品
• 装置
• 服务

全球长读长定序市场规模（依技术划分）及复合年增长率（2026-2033 年）

• 奈米孔定序
• 单分子即时定序
• 合成长读定序

全球长读长定序市场规模（依工作流程及复合年增长率划分）（2026-2033 年）

• 定序
• 样品製备
• 数据分析

全球长读长定序市场规模（依应用及复合年增长率划分）（2026-2033 年）

• 全基因组定序
• 标靶定序
• 总体基因体学
• 表观遗传学
• 全外EXOME定序
• 其他用途

全球长读长定序市场规模（按用途和复合年增长率划分）（2026-2033 年）

• 研究
• 临床

全球长读长定序市场规模（以最终用户划分）及复合年增长率（2026-2033 年）

• 学术和研究机构
• 医院、诊所和诊断检查室
• 製药和生物技术公司
• 其他最终用户

全球长读长定序市场规模（按地区划分）及复合年增长率（2026-2033 年）

• 北美洲
  • 美国
  • 加拿大
• 欧洲
  • 德国
  • 西班牙
  • 法国
  • 英国
  • 义大利
  • 其他欧洲地区
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 韩国
  • 亚太其他地区
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲地区
• 中东和非洲
  • 海湾合作委员会国家
  • 南非
  • 其他中东和非洲地区

竞争资讯

• 前五大公司对比
• 主要企业的市场定位（2025 年）
• 主要市场参与者所采取的策略
• 近期市场趋势
• 公司市占率分析（2025 年）
• 主要企业公司简介
  • 公司详情
  • 产品系列分析
  • 依业务板块进行公司股票分析
  • 2023-2025年营收年比比较

主要企业简介

• Pacific Biosciences of California, Inc.（PacBio）（United States）
• Oxford Nanopore Technologies plc（United Kingdom）
• Illumina, Inc.（United States）
• BGI Genomics Co., Ltd.（China）
• 10x Genomics, Inc.（United States）
• Agilent Technologies, Inc.（United States）
• Thermo Fisher Scientific Inc.（United States）
• QIAGEN NV（Germany）
• Takara Bio Inc.（Japan）
• Danaher Corporation（United States）
• Novogene Co., Ltd.（China）
• New England Biolabs, Inc.（United States）
• Element Biosciences, Inc.（United States）
• Revvity, Inc.（United States）
• Eurofins Scientific SE（Luxembourg）
• Bio-Rad Laboratories, Inc.（United States）
• PerkinElmer, Inc.（United States）
• Roche Holding AG（Switzerland）
• Merck KGaA（Germany）
• Bio-Techne Corporation（United States）

结论与建议

Global Long Read Sequencing Market size was valued at USD 779.92 Million in 2024 and is poised to grow from USD 1020.92 Million in 2025 to USD 8800.49 Million by 2033, growing at a CAGR of 30.9% during the forecast period (2026-2033).

The global market for long read sequencing (LRS) is being driven by the rising incidence of genetic disorders, the increasing appeal of personalized medicine, and significant technological advancements like third-generation sequencing. The demand for innovative sequencing techniques has surged due to their utility in diagnostics and drug development, particularly influenced by the global health crisis. LRS, including methods like Single Molecule Real Time (SMRT) and Nanopore sequencing, offers distinct advantages such as accurate genome assembly and the detection of complex genomic features that traditional sequencing struggles to identify. Enhanced capability to analyze challenging genetic regions and chromosomal abnormalities positions LRS as a pivotal tool in clinical research, while major investments in advanced genomic technologies from industry leaders promise to further accelerate market growth.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Long Read Sequencing market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Long Read Sequencing Market Segments Analysis

Global Long Read Sequencing Market is segmented by Offerings, Technology, Workflow, Application, Usage, End Users and region. Based on Offerings, the market is segmented into Consumables, Instruments and Services. Based on Technology, the market is segmented into Nanopore sequencing, Single-molecule real-time sequencing and Synthetic long-read sequencing. Based on Workflow, the market is segmented into Sequencing, Sample Preparation and Data analysis. Based on Application, the market is segmented into Whole Genome Sequencing, Targeted Sequencing, Metagenomics, Epigenetics, Whole exome sequencing and Other applications. Based on Usage, the market is segmented into Research and Clinical. Based on End Users, the market is segmented into Academic & Research Institutes, Hospitals, Clinics & Diagnostic Labs, Pharmaceutical & Biotechnology Companies and Other End Users. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Long Read Sequencing Market

The global market for Long Read Sequencing is significantly propelled by the widespread utilization of next-generation sequencing (NGS) technologies in diverse research domains such as genomics, transcriptomics, and epigenomics. The ability of long read sequencing to enhance our understanding of genome assembly, gene expression, and DNA modification patterns contributes greatly to its growing acceptance and integration into NGS-focused research initiatives. Researchers increasingly rely on this technology for its ability to provide deeper insights and more comprehensive data, thereby fostering innovation and advancements in various scientific disciplines and promoting its extensive adoption within the global research community.

Restraints in the Global Long Read Sequencing Market

The global long read sequencing market faces challenges due to the comparatively higher expenses associated with these technologies when measured against traditional short read sequencing methods. The financial burden stems from the costs of specialized instruments, reagents, and comprehensive data analysis, which can be substantial. This economic factor can hinder the widespread adoption of long read sequencing in various environments, particularly in clinical diagnostics and research facilities that may have limited resources. As a result, cost considerations may restrict the integration of these advanced sequencing solutions into more routine applications and settings.

Market Trends of the Global Long Read Sequencing Market

The Global Long Read Sequencing market is experiencing robust growth as researchers and healthcare professionals increasingly recognize the superiority of long read technologies for delivering detailed and precise genomic insights. This shift is fueled by a burgeoning demand across diverse applications, including genome assembly, structural variant analysis, and transcriptomics. As the limitations of traditional short read sequencing become more apparent, the industry is witnessing a heightened emphasis on innovative solutions that can navigate complex genetic landscapes. The ongoing advancements in long read sequencing technologies are poised to further catalyze their adoption, enhancing research capabilities and driving personalized medicine forward.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2025
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Technological Advancement
• Regulatory Landscape

Global Long Read Sequencing Market Size by Offerings & CAGR (2026-2033)

• Market Overview
• Consumables
• Instruments
• Services

Global Long Read Sequencing Market Size by Technology & CAGR (2026-2033)

• Market Overview
• Nanopore sequencing
• Single-molecule real-time sequencing
• Synthetic long-read sequencing

Global Long Read Sequencing Market Size by Workflow & CAGR (2026-2033)

• Market Overview
• Sequencing
• Sample Preparation
• Data analysis

Global Long Read Sequencing Market Size by Application & CAGR (2026-2033)

• Market Overview
• Whole Genome Sequencing
• Targeted Sequencing
• Metagenomics
• Epigenetics
• Whole exome sequencing
• Other applications

Global Long Read Sequencing Market Size by Usage & CAGR (2026-2033)

• Market Overview
• Research
• Clinical

Global Long Read Sequencing Market Size by End Users & CAGR (2026-2033)

• Market Overview
• Academic & Research Institutes
• Hospitals, Clinics & Diagnostic Labs
• Pharmaceutical & Biotechnology Companies
• Other End Users

Global Long Read Sequencing Market Size & CAGR (2026-2033)

• North America (Offerings, Technology, Workflow, Application, Usage, End Users)
  • US
  • Canada
• Europe (Offerings, Technology, Workflow, Application, Usage, End Users)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Offerings, Technology, Workflow, Application, Usage, End Users)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Offerings, Technology, Workflow, Application, Usage, End Users)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Offerings, Technology, Workflow, Application, Usage, End Users)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

• Pacific Biosciences of California, Inc. (PacBio) (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Oxford Nanopore Technologies plc (United Kingdom)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Illumina, Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• BGI Genomics Co., Ltd. (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• 10x Genomics, Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Agilent Technologies, Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Thermo Fisher Scientific Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• QIAGEN N.V. (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Takara Bio Inc. (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Danaher Corporation (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Novogene Co., Ltd. (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• New England Biolabs, Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Element Biosciences, Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Revvity, Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Eurofins Scientific SE (Luxembourg)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bio-Rad Laboratories, Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• PerkinElmer, Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Roche Holding AG (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merck KGaA (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bio-Techne Corporation (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations